Analyst Ratings for aTyr Pharma (ATYR)
ATYR Rating Summary
ATYR Price Target Summary
- Highest: $3.00 (Jefferies)
- Lowest: $1.00 (Wells Fargo)
- Average: $1.40
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$1.40 (+70.7%)
* Over Last 12-Mos
Rating Score: 2.2 / 10
Percentile Rank: 17%
Rating Score: 2.2 / 10
Percentile Rank: 17%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/15/2025 | RBC Capital » Updated 11/7/2025 |
Brian Abrahams | Downgrade | Sector Perform (Outperform) |
1.00 (1.50) |
6.03 (0.82) |
-86.4% | Details |
| 9/15/2025 | Wells Fargo | N/A | Downgrade | Equal Weight (Overweight) |
1.00 (N/A) |
6.03 (0.82) |
-86.4% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
